Quality stroke care at Good Samaritan recognized by American Heart Association
Release Date: July 12, 2017
KEARNEY - CHI Health Good Samaritan recently received the American Heart Association/American Stroke Association’s Get With The Guidelines®-Stroke Gold Plus Quality Achievement Award with Target: StrokeSM Honor Roll. The award recognizes Good Samaritan’s commitment to providing the most appropriate stroke treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
To qualify for the Target: Stroke Honor Roll, Good Samaritan met quality measures developed to reduce the time between a patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability. Good Samaritan earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period.
“A stroke patient loses 1.9 million neurons each minute treatment is delayed,” said Pamela Palmer, neurology APRN. At Good Samaritan we are continually advancing, finding better ways to treat strokes faster and more safely. This award just reinforces our team’s drive to provide the most up-to-date care to our friends and neighbors.”
Good Samaritan has been a Primary Stroke Center since 2011 and treats more than 200 stroke patients yearly.
Developed with the goal to save lives and improve recovery time, Get With The Guidelines®-S has impacted more than 6 million patients since 2001. For more information, visit heart.org.